Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Graft-versus-host disease | R-HSA-1643685 | map05332 | fosfosal | 5280445 | drug-path |
| Base excision repair | R-HSA-73884 | map03410 | fosfosal | 5280445 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | fosfosal | 5280445 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | fosfosal | 5280445 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | fosfosal | 5280445 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | trichlormethiazide | 223368 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | trichlormethiazide | 223368 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | trichlormethiazide | 223368 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | trichlormethiazide | 223368 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | trichlormethiazide | 223368 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | trichlormethiazide | 223368 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | trichlormethiazide | 223368 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | estropipate | 5284555 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | estropipate | 5284555 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | estropipate | 5284555 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | estropipate | 5284555 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | estropipate | 5284555 | drug-path |
| Asthma | R-HSA-444620 | map05310 | estropipate | 5284555 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | estropipate | 5284555 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | estropipate | 5284555 | drug-path |